Agile Therapeutics Inc

NASDAQ:AGRX  
1.52
+0.17 (+12.59%)
Earnings Announcements

Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results

Published: 03/30/2022 20:21 GMT
Agile Therapeutics Inc (AGRX) - Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update.
Q4 Loss per Share $0.20.
Revenue is expected to be $1.84 Million
Adjusted EPS is expected to be -$4.61

Next Quarter Revenue Guidance is expected to be $2.2 Million
Next Quarter EPS Guidance is expected to be -$4.34

More details on our Analysts Page.